Founded in 2003, we are a research and consulting group specialized in four areas

Real-world clinical evidence in human therapeutics

  • Scientific strategy, portfolio management, and lifecycle integration
  • Scientific consulting
  • Study design and management
  • Advanced modeling and analytics
  • Scientific and technical review, due diligence, and validation
  • Scientific and professional communication
  • Virtual health outcomes research services

Value, economics, and equity

  • Pharmaco- and health economics
  • Value of human therapeutics
  • Access to and equity in human therapeutics
  • Outcomes-based pricing and contracting of human therapeutics
  • Value of information analysis
  • Simulation of budget impact, savings, and (re-)allocation
  • Alternate and novel metrics of benefit and harm
  • Shadow modeling of health technology assessment appraisals
  • Virtual health economics services

Expert review, expert opinion and litigation support

  • Scientific and technical review, due diligence, and validation
  • Knowledge and data synthesis
  • Risk analysis and management
  • Expert evidence and testimony

Evidence-based healthcare and clinical translation

  • Evidence synthesis, translation, and application
  • Systematic reviews and meta-analyses
  • Clinical risk management, evidence-based support, and outcomes assessment
  • Best practice guidelines